But it is still not a simple one-size-fits-all substitution
More specifically, the FDA label states that these medications may lead to thyroid C-cell tumors
The color should be uniform throughout the vial with no darker spots, streaks, or gradients
Therefore, the uptake, release, storage and transport of iron ions in cells are all important factors affecting iron death
Clinical trials vs real-world results What the clinical trials show The landmark SURMOUNT-5 trial published in 2025 compared these medications directly at standard maximum doses: 1 Mounjaro (tirzepatide 15 mg) produced 20.2% average weight loss Wegovy (semaglutide 2.4 mg) produced 13.7% average weight loss The 6.5 percentage point difference was statistically significant This trial used the maximum approved doses at the time (Mounjaro 15 mg, Wegovy 2.4 mg) and lasted 72 weeks
Not intended for human consumption, medical treatment, or veterinary application.